Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: Evidence from a comprehensive network meta-analysis

Journal of the American College of Cardiology

Volumn 62, Issue 6, 2013, Pages 496-504

  Palmerini, Tullio ^a   Biondi Zoccai, Giuseppe ^b   Della Riva, Diego ^a   Mariani, Andrea ^a   Sabaté, Manel ^c   Valgimigli, Marco ^d   Frati, Giacomo ^b   Kedhi, Elvin ^e   Smits, Pieter C ^e   Kaiser, Christoph ^f   Genereux, Philippe ^g   Galatius, Soren ^h   Kirtane, Ajay J ^g   Stone, Gregg W ^g  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c HOSPITAL CLÍNIC   (Spain)

^d UNIVERSITY OF FERRARA   (Italy)

^e Maasstad Hospital Rotterdam   (Netherlands)

^f UNIVERSITY HOSPITAL BASEL   (Switzerland)

^g NewYork Presbyterian Hospital   (United States)

^h GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

bare metal stent(s); drug eluting stent(s); meta analysis; stent thrombosis

Indexed keywords

CHROMIUM; COBALT; EVEROLIMUS; PACLITAXEL; ZOTAROLIMUS;

ARTICLE; BARE METAL STENT; CARDIOVASCULAR MORTALITY; CLINICAL EFFECTIVENESS; CORONARY ARTERY RECANALIZATION; DRUG ELUTING STENT; FOLLOW UP; HEART INFARCTION; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; META ANALYSIS; OUTCOME ASSESSMENT; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); ST SEGMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

BARE-METAL STENT(S); BMS; COBALT-CHROMIUM EVEROLIMUS-ELUTING STENT(S); COCR-EES; DES; DRUG-ELUTING STENT(S); META-ANALYSIS; PACLITAXEL-ELUTING STENT(S); PC-ZES; PCI; PERCUTANEOUS CORONARY INTERVENTION; PES; PHOSPHORYLCHOLINE-BASED ZOTAROLIMUS-ELUTING STENT(S); PREFERRED REPORTING ITEMS FOR SYSTEMATIC REVIEWS AND META-ANALYSES; PRISMA; RANDOMIZED CONTROLLED TRIAL; RCT; SES; SIROLIMUS-ELUTING STENT(S); ST-SEGMENT ELEVATION ACUTE MYOCARDIAL INFARCTION; STEMI; STENT THROMBOSIS; STTHR; TARGET VESSEL REVASCULARIZATIONS; TVR;

DRUG-ELUTING STENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYOCARDIAL INFARCTION; PACLITAXEL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SIROLIMUS; STENTS; TREATMENT OUTCOME; TUBULIN MODULATORS;

EID: 84881086164     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.05.022     Document Type: Article

References (28)

1. E.M. Antman, M. Hand, and P.W. Armstrong 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 51 2008 210 247
2. G.W. Stone, C.L. Grines, and D.A. Cox Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction N Engl J Med 346 2002 957 966
3. C. Spaulding, E. Teiger, and P. Commeau Four-year follow-up of TYPHOON (trial to assess the use of the CYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty) J Am Coll Cardiol Intv 4 2011 14 23
4. E.L. Eisenstein, K.J. Anstrom, and D.F. Kong Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation JAMA 297 2007 159 168
5. M. Pfisterer, H.P. Brunner-La Rocca, and P.T. Buser Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents J Am Coll Cardiol 48 2006 2584 2591
6. J. Daemen, P.H. van Twisk, and N. Kukreja The relative safety and efficacy of bare-metal and drug-eluting stents in low and high-risk patient subsets. An epidemiological analysis of three sequential cohorts of consecutive all comers (n = 6129) EuroIntervention 4 2009 464 474
7. P.A. Merlini, K.A. Bauer, and L. Oltrona Persistent activation of coagulation mechanism in unstable angina and myocardial infarction Circulation 90 1994 61 68
8. C. Kaiser, S. Galatius, and P. Erne Drug-eluting versus bare-metal stents in large coronary arteries N Engl J Med 363 2010 2310 2319
9. M. Sabate, A. Cequier, and A. Iniguez Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial Lancet 380 2012 1482 1490
10. S.S. Brar, M.B. Leon, and G.W. Stone Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis J Am Coll Cardiol 53 2009 1677 1689
11. G. De Luca, M.T. Dirksen, and C. Spaulding Drug-eluting vs. bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials Arch Intern Med 172 2012 611 621
12. F. Song, I. Harvey, and R. Lilford Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions J Clin Epidemiol 61 2008 455 463
13. A. Liberati, D.G. Altman, and J. Tetzlaff The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration BMJ 339 2009 b2700
14. E. Kedhi, K.S. Joesoef, and E. McFadden Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial Lancet 375 2010 201 209
15. M. Valgimigli, G. Campo, and M. Monti Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial Circulation 125 2012 2015 2026
16. M. Valgimigli, G. Campo, and G. Percoco Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial JAMA 299 2008 1788 1799
17. B. Kalesan, T. Pilgrim, and K. Heinimann Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction Eur Heart J 33 2012 977 987
18. G. Guagliumi, M.A. Costa, and V. Sirbu Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial Circulation 123 2011 274 281
19. G. Nakazawa, A.V. Finn, and M. Joner Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study Circulation 118 2008 1138 1145
20. G.W. Stone, A. Rizvi, and W. Newman Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease N Engl J Med 362 2010 1663 1674
21. K. Kolandaivelu, R. Swaminathan, and W.J. Gibson Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings Circulation 123 2011 1400 1409
22. C. Bauters, M. Delomez, E. Van Belle, E. McFadden, J.M. Lablanche, and M.E. Bertrand Angiographically documented late reocclusion after successful coronary angioplasty of an infarct-related lesion is a powerful predictor of long-term mortality Circulation 99 1999 2243 2250
23. G.W. Stone, B. Witzenbichler, and G. Guagliumi Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial Lancet 377 2011 2193 2204
24. S.D. Wiviott, E. Braunwald, and C.H. McCabe Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
25. M.S. Chen, J.M. John, D.P. Chew, D.S. Lee, S.G. Ellis, and D.L. Bhatt Bare metal stent restenosis is not a benign clinical entity Am Heart J 151 2006 1260 1264
26. R. Mehran, S.J. Pocock, and E. Nikolsky A risk score to predict bleeding in patients with acute coronary syndromes J Am Coll Cardiol 55 2010 2556 2566
27. S. Bangalore, S. Kumar, and M. Fusaro Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials Circulation 125 2012 2873 2891
28. T. Palmerini, G. Biondi-Zoccai, and D. Della Riva Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis Lancet 379 2012 1393 1402